[Use of 19-nor-17 alpha-hydroxyprogesterone caproate in endometrial cancer].
D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D002278:Carcinoma in Situ / Q000188:drug therapy*; D004717:Endometrium / Q000473:pathology; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000627:therapeutic use*; D007044:Hysterectomy; D008875:Middle Aged; D014594:Uterine Neoplasms / Q000188:drug therapy*
D006908:Hydroxyprogesterones
Uso del capronato de 19 nor-17 alfa hidroxiprogesterona en el cáncer de endometrio.